Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2021 / 06:10PM GMT
Release Date Price: $52.8 (+1.70%)
Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Good afternoon, and good evening, and thank you all for joining us. My name is Keyur Parekh, and I cover Sanofi for Goldman Sachs. It is my distinct honor and privilege to welcome John Reed for this fireside chat. John, thank you very much for joining us.

John C. Reed
Sanofi - Executive VP and Global Head of Research & Development

Great to be here, Keyur.

Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst

As most of you know, John is Executive Vice President and Head of R&D for Sanofi. And I believe, John, this is your first kind of Goldman Sachs conference. And it's a shame that we're doing this virtually and not in person at [Terranea]. But hopefully, we will resolve that soon enough.

John C. Reed
Sanofi - Executive VP and Global Head of Research & Development

No, it's great to be here. Thanks for the opportunity. I look forward to having this chat with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot